Aerobiology matters: Why people in the community access pollen information and how they use it

IF 4.6 2区 医学 Q2 ALLERGY
Danielle E. Medek, Constance H. Katelaris, Andelija Milic, Paul J. Beggs, Edwin R. Lampugnani, Don Vicendese, Bircan Erbas, Janet M. Davies
{"title":"Aerobiology matters: Why people in the community access pollen information and how they use it","authors":"Danielle E. Medek,&nbsp;Constance H. Katelaris,&nbsp;Andelija Milic,&nbsp;Paul J. Beggs,&nbsp;Edwin R. Lampugnani,&nbsp;Don Vicendese,&nbsp;Bircan Erbas,&nbsp;Janet M. Davies","doi":"10.1002/clt2.70031","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Globally, many pollen monitoring networks provide the community with daily pollen information, but there are limited data on health consumer uses and benefits. This research investigated why individuals in the community access pollen information, how they use it, and the perceived benefits.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>In- and post-pollen season surveys (2017–2018 and 2018–2019) enquired about symptoms, diagnoses, symptom management, access, benefits and usefulness of pollen information provided by the AusPollen Partnership. Open text responses were examined by thematic analysis. Theme frequency and quantitative data were compared across pollen seasons, within and after the season, and between respondents with and without access to AusPollen information.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Surveys were completed 4044 times by 3604 individuals who predominantly self-reported severe and frequent allergic rhinitis symptoms. Local AusPollen information was accessible to 84.6% of participants, and was reportedly used for preparation and planning (34.6%), guiding activities (32.9%), and medication decisions (28.2%). When asked how pollen information helped, similar themes were evident; but 16.1% also mentioned safety for themselves and others. However, secondary analysis of survey responses indicated that self-reported medication use did not differ between those with or without access to pollen information or between time points surveyed. Suggestions for improvement included extended duration (16.4%), wider geographic range (13.5%), and information on other taxa (17.2%).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>There was a perceived need for localised, detailed and timely pollen information by people with pollen allergy. Whilst responses suggested this helped inform behaviours linked to allergen avoidance, further education strategies on allergic rhinitis control are needed to support patients who self-manage their condition.</p>\n </section>\n </div>","PeriodicalId":10334,"journal":{"name":"Clinical and Translational Allergy","volume":"15 1","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11761002/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Allergy","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/clt2.70031","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Globally, many pollen monitoring networks provide the community with daily pollen information, but there are limited data on health consumer uses and benefits. This research investigated why individuals in the community access pollen information, how they use it, and the perceived benefits.

Methods

In- and post-pollen season surveys (2017–2018 and 2018–2019) enquired about symptoms, diagnoses, symptom management, access, benefits and usefulness of pollen information provided by the AusPollen Partnership. Open text responses were examined by thematic analysis. Theme frequency and quantitative data were compared across pollen seasons, within and after the season, and between respondents with and without access to AusPollen information.

Results

Surveys were completed 4044 times by 3604 individuals who predominantly self-reported severe and frequent allergic rhinitis symptoms. Local AusPollen information was accessible to 84.6% of participants, and was reportedly used for preparation and planning (34.6%), guiding activities (32.9%), and medication decisions (28.2%). When asked how pollen information helped, similar themes were evident; but 16.1% also mentioned safety for themselves and others. However, secondary analysis of survey responses indicated that self-reported medication use did not differ between those with or without access to pollen information or between time points surveyed. Suggestions for improvement included extended duration (16.4%), wider geographic range (13.5%), and information on other taxa (17.2%).

Conclusion

There was a perceived need for localised, detailed and timely pollen information by people with pollen allergy. Whilst responses suggested this helped inform behaviours linked to allergen avoidance, further education strategies on allergic rhinitis control are needed to support patients who self-manage their condition.

Abstract Image

空气生物学的重要性:为什么人们在社区访问花粉信息和他们如何使用它。
背景:在全球范围内,许多花粉监测网络为社区提供每日花粉信息,但关于健康消费者使用和益处的数据有限。本研究调查了群落中个体获取花粉信息的原因,他们如何使用花粉信息以及感知到的好处。方法:通过花粉季调查(2017-2018年和2018-2019年),了解AusPollen Partnership提供的花粉信息的症状、诊断、症状管理、获取、益处和有用性。开放文本回复通过主题分析进行检验。比较了不同花粉季节、花粉季内和花粉季后、有和没有获得AusPollen信息的受访者之间的主题频率和定量数据。结果:3604名主要自我报告严重和频繁变应性鼻炎症状的个体完成了4044次调查。84.6%的参与者可访问本地AusPollen信息,据报道用于准备和计划(34.6%),指导活动(32.9%)和药物决策(28.2%)。当被问及花粉信息如何起作用时,相似的主题很明显;但16.1%的人也提到了自己和他人的安全。然而,对调查结果的二次分析表明,自我报告的药物使用情况在有或没有获得花粉信息的人之间或调查时间点之间没有差异。改进建议包括延长生存期(16.4%)、扩大地理范围(13.5%)和其他分类群的信息(17.2%)。结论:花粉过敏人群对花粉信息的需求是局部的、详细的、及时的。虽然反应表明这有助于告知与过敏原避免相关的行为,但需要进一步的变应性鼻炎控制教育策略,以支持自我管理病情的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical and Translational Allergy
Clinical and Translational Allergy Immunology and Microbiology-Immunology
CiteScore
7.50
自引率
4.50%
发文量
117
审稿时长
12 weeks
期刊介绍: Clinical and Translational Allergy, one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology, provides a platform for the dissemination of allergy research and reviews, as well as EAACI position papers, task force reports and guidelines, amongst an international scientific audience. Clinical and Translational Allergy accepts clinical and translational research in the following areas and other related topics: asthma, rhinitis, rhinosinusitis, drug hypersensitivity, allergic conjunctivitis, allergic skin diseases, atopic eczema, urticaria, angioedema, venom hypersensitivity, anaphylaxis, food allergy, immunotherapy, immune modulators and biologics, animal models of allergic disease, immune mechanisms, or any other topic related to allergic disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信